Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

LRRK2 activation in idiopathic Parkinson's disease.

Di Maio R, Hoffman EK, Rocha EM, Keeney MT, Sanders LH, De Miranda BR, Zharikov A, Van Laar A, Stepan AF, Lanz TA, Kofler JK, Burton EA, Alessi DR, Hastings TG, Greenamyre JT.

Sci Transl Med. 2018 Jul 25;10(451). pii: eaar5429. doi: 10.1126/scitranslmed.aar5429.

PMID:
30045977
2.

Reliability of parent report measures of behaviour in children with Down syndrome.

Esbensen AJ, Hoffman EK, Shaffer R, Chen E, Patel L, Jacola L.

J Intellect Disabil Res. 2018 Sep;62(9):785-797. doi: 10.1111/jir.12533. Epub 2018 Jul 18.

PMID:
30022564
3.

Impact of sleep on executive functioning in school-age children with Down syndrome.

Esbensen AJ, Hoffman EK.

J Intellect Disabil Res. 2018 Jun;62(6):569-580. doi: 10.1111/jir.12496. Epub 2018 Apr 25.

PMID:
29696706
4.

Convergent validity of actigraphy with polysomnography and parent reports when measuring sleep in children with Down syndrome.

Esbensen AJ, Hoffman EK, Stansberry E, Shaffer R.

J Intellect Disabil Res. 2018 Apr;62(4):281-291. doi: 10.1111/jir.12464. Epub 2018 Jan 5.

PMID:
29314419
5.

Links between sleep and daytime behaviour problems in children with Down syndrome.

Esbensen AJ, Hoffman EK, Beebe DW, Byars KC, Epstein J.

J Intellect Disabil Res. 2018 Feb;62(2):115-125. doi: 10.1111/jir.12463. Epub 2017 Dec 28.

PMID:
29282827
6.

Use of Sleep Evaluations and Treatments in Children with Down Syndrome.

Esbensen AJ, Beebe DW, Byars KC, Hoffman EK.

J Dev Behav Pediatr. 2016 Oct;37(8):629-36. doi: 10.1097/DBP.0000000000000333.

7.

Reliability of parent report measures of sleep in children with Down syndrome.

Esbensen AJ, Hoffman EK.

J Intellect Disabil Res. 2017 Mar;61(3):210-220. doi: 10.1111/jir.12315. Epub 2016 Jul 28.

8.

α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease.

Di Maio R, Barrett PJ, Hoffman EK, Barrett CW, Zharikov A, Borah A, Hu X, McCoy J, Chu CT, Burton EA, Hastings TG, Greenamyre JT.

Sci Transl Med. 2016 Jun 8;8(342):342ra78. doi: 10.1126/scitranslmed.aaf3634.

9.

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.

Mastroberardino PG, Hoffman EK, Horowitz MP, Betarbet R, Taylor G, Cheng D, Na HM, Gutekunst CA, Gearing M, Trojanowski JQ, Anderson M, Chu CT, Peng J, Greenamyre JT.

Neurobiol Dis. 2009 Jun;34(3):417-31. doi: 10.1016/j.nbd.2009.02.009. Epub 2009 Feb 26.

10.

A reliable behavioral assay for the assessment of sustained photophobia in mice.

Thiels E, Hoffman EK, Gorin MB.

Curr Eye Res. 2008 May;33(5):483-91. doi: 10.1080/02713680802130347. Erratum in: Curr Eye Res. 2008 Aug;33(8):725.

PMID:
18568886
11.

Dopaminergic mutations: within-family association and linkage in multiplex alcohol dependence families.

Hill SY, Hoffman EK, Zezza N, Thalamuthu A, Weeks DE, Matthews AG, Mukhopadhyay I.

Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 5;147B(4):517-26.

12.
13.

A genome wide search for alcoholism susceptibility genes.

Hill SY, Shen S, Zezza N, Hoffman EK, Perlin M, Allan W.

Am J Med Genet B Neuropsychiatr Genet. 2004 Jul 1;128B(1):102-13.

14.

Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (Sod1) increases susceptibility to noise-induced hearing loss.

Ohlemiller KK, McFadden SL, Ding DL, Flood DG, Reaume AG, Hoffman EK, Scott RW, Wright JS, Putcha GV, Salvi RJ.

Audiol Neurootol. 1999 Sep-Oct;4(5):237-46.

PMID:
10436316
15.

Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions.

Flood DG, Reaume AG, Gruner JA, Hoffman EK, Hirsch JD, Lin YG, Dorfman KS, Scott RW.

Am J Pathol. 1999 Aug;155(2):663-72.

16.

Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts.

Huang TT, Yasunami M, Carlson EJ, Gillespie AM, Reaume AG, Hoffman EK, Chan PH, Scott RW, Epstein CJ.

Arch Biochem Biophys. 1997 Aug 15;344(2):424-32.

PMID:
9264557
17.

Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia.

Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, Chan PH.

J Neurosci. 1997 Jun 1;17(11):4180-9.

18.
19.

Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury.

Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH Jr, Scott RW, Snider WD.

Nat Genet. 1996 May;13(1):43-7.

PMID:
8673102
20.

Structure and organization of amplified DNA on double minutes containing the mdm2 oncogene.

Fakharzadeh SS, Rosenblum-Vos L, Murphy M, Hoffman EK, George DL.

Genomics. 1993 Feb;15(2):283-90.

PMID:
8449492
21.

Induction of NGF by isoproterenol, 4-methylcatechol and serum occurs by three distinct mechanisms.

Carswell S, Hoffman EK, Clopton-Hartpence K, Wilcox HM, Lewis ME.

Brain Res Mol Brain Res. 1992 Sep;15(1-2):145-50.

PMID:
1331660
22.

An S1 nuclease-sensitive homopurine/homopyrimidine domain in the c-Ki-ras promoter interacts with a nuclear factor.

Hoffman EK, Trusko SP, Murphy M, George DL.

Proc Natl Acad Sci U S A. 1990 Apr;87(7):2705-9.

23.

Transcriptional activation of cKi-ras proto-oncogene resulting from retroviral promoter insertion.

Trusko SP, Hoffman EK, George DL.

Nucleic Acids Res. 1989 Nov 25;17(22):9259-65.

24.

The upstream promoter of the human LDL receptor gene does not contain a cyclic AMP response element.

Takagi K, Hoffman EK, Strauss JF 3rd.

Biochem Biophys Res Commun. 1988 Apr 15;152(1):143-8.

PMID:
2833885
25.

Structural and functional characterization of the promoter region of the mouse c-Ki-ras gene.

Hoffman EK, Trusko SP, Freeman N, George DL.

Mol Cell Biol. 1987 Jul;7(7):2592-6.

Supplemental Content

Loading ...
Support Center